James Iles

Top Topics: Sells for $904,000; How Do You Manage 1,500 Domains?...

By James Iles, Mar 28, 2021
  1. In this week's Top Topics, George Kirikos uncovers the $904,000 sale of, acquired by Recursion Pharmaceuticals. Elsewhere, a domain owner needs advice on managing a portfolio of 1,500 domain names, and we share a cautionary tale of an accidental $3,488 domain name purchase.

    How Do You Manage 1,500 Domains?

    Some domain name investors may own tens or hundreds of domain names, but many are operating portfolios totaling thousands of domain names. When you have so many domain names, it can be difficult to know exactly what to do to generate revenue.

    Here, the owner of a 1,500 portfolio of domain names is asking for advice on monetizing the domain names. Would parking, development, or pure domain sales be the preferable option?

    Topic by: @FrasierCrane

    A Cautionary Tale

    A domain investor has shared a cautionary tale of an accidental $3,488 purchase. While browsing, this domainer found a four-letter .COM domain at SnapNames and placed a backorder on that name.

    The next day, the domainer received an email confirming the $3,488 purchase of this four-letter .COM. According to the discussion, it's easy to inadvertently buy a domain name at SnapNames for a "buy now" price rather than simply submitting a backorder bid.

    Topic by: @Edcy

    My 3 Years in Domaining

    This investor has taken the decision to leave domaining, but not before candidly sharing details of their overall experience as a domain investor along with a list of sales. The investor focused on quick flips and managed to make a $6,000 profit as a domainer.

    The discussion includes a long list of the investor's domain sales including both the losses, such as a $40 acquisition sold for $5 and a $45 domain sold for $650.

    Topic by: @Truespin Domains Changed Hands for $904,000

    Domain investor George Kirikos has a long track record of discovering six- and seven-figure domain sales via SEC filings. Recently, Kirikos uncovered the $503,000 sale of, and now he's back with another find.

    According to a recent SEC filing, Recursion Pharmaceuticals acquired the domain name in December 2020 for $904,000. Kirikos also mentions in this discussion that Recursion Pharmaceuticals raised $239 million in a September 2020 funding round. The company has recently filed to go public.

    Topic by: @GeorgeK

    Top Topics of the Week is a blog series featuring the most popular discussions and content within the domain community. Tune in weekly to see what’s trending
    The views expressed on this page by users and staff are their own, not those of NamePros.
  2. Next Article
    What Does The NFT Craze Mean For Domain Names?
    Previous Article
    Nine Things About NET Domain Names
  3. Loading...
  4. James Iles

    About The Author — James Iles

    James is a domain name industry writer. Contact james (at) For all inquiries relating to NamePros stories and interviews, please email: [email protected] For James' own blog, visit

    This is James Iles's 759th blog post on NamePros. View all blog posts

    Home Page:
  5. Comments (6)

  6. The Durfer

    The Durfer Top Contributor VIP Gold Account

    Likes Received:
  7. PRO VIP ★★★★★★★★★★

    Likes Received:
    Thanks for another nice roundup of articles (y)
  8. wot

    wot Top Contributor VIP ★★★★★★★★★★

    Likes Received:
    I read the definition of recursion and still do no know what it means!
  9. PhongSGC

    PhongSGC Top Contributor VIP

    Likes Received:
    yeah, thank you @James Iles , this is your first post I clicked all inside topics to read more :xf.grin:
    Last edited: Mar 29, 2021
  10. Sam Nelson

    Sam Nelson Account Closed (Disallowed)

    Likes Received:
    Thanks James for this informative article!
  11. Iamcherry

    Iamcherry New Member

    Likes Received:
    Thanks James For sharing this information
  1. NamePros uses cookies and similar technologies. By using this site, you are agreeing to our privacy policy, terms, and use of cookies.
    Dismiss Notice